Gene Query: CDHR5

Dataset Description Geneva Score
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 68.19
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 56.83
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 53.61
Total RNA sequencing of WT intestinal orgaonids. 37.16
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 33.39
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 29.58
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 28.1
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 23.82
Single-nucleotide-resolution mapping of HBV promoters using CAGE 21.51
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 19.73
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 19.35
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 18.55
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 18.55
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 17.93
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 17.92
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 17.61
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 17.49
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 17.06
RNA seq analysis of human Fetal and adult derived Enterospheres 16.22
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 14.78
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 14.69
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 14.34
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 13.97
Gene expression analysis of human liver progenitor-like cells in culture 13.89
Gene expression profile difference among renal location in a stone former 13.84
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 13.37
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 12.43
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 12.09
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 12.04
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 10.76
The expression profiles of GBC liver metastasis 10.21
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 10.11
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 10.06
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 9.89
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 9.85
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 9.79
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 9.55
Transcriptional profiling of LS1034 cells treated with tepoxalin 9.38
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 8.91
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 8.86
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 8.17
Comparing gene expression in iPSC derived RPE from control and AMD donors 8.08
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 7.98
Total RNA sequencing of APC mutant and wt colonic organoids 7.58
High-Throughput Kinetic Analysis of Fractional Killing 7.46
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 7.34
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 6.8
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 6.78
Genome-wide identification of cancer-specific alternative splicing in circRNA 6.31
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 6.31
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 6.28
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 6.2
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 6.13
Expression charcaterization of an internal protocol developed to differentiate RPE cells 6.07
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 5.56
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 4.99
Molecular analysis of renal cell carcinoma with unclassfied histology 4.99
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 4.95
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 4.95
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.92
RNA-sequencing 4.73
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 4.69
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 4.56
Recovery and analysis of nascent RNA 4.54
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 4.54
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 4.49
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 4.49
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.37
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 4.26
Gene expression alterations of pancreatic intraepithlial neoplasia 4.16
Universal alternative splicing of noncoding exons 4.11
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 3.82
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 3.67
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 3.67
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 3.67
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.63
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.58
RNA sequencing of human pancreatic cancer cell lines 3.56
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 3.52
Gene expression analysis of human hepatocellular cancers 3.51
RNA-Seq analysis of human colorectal cancer with liver metastasis 3.48
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.23
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 3.22
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 3.22
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 3.22
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.2
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 3.11
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 3.05
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.91
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 2.74
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 2.71
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.62
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 2.59
Common inflammatory pathways between NEC and Crohn's disease 2.55
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.46
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 2.41
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.33
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.32
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.3
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.23
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 2.19
RNA Sequencing of three pairs of gastric cancer 2.18
Hepatic transcriptome of pediatric hepatoblastoma. 2.15
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 2.11
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 2.07
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 2.07
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 2.03
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.96
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.94
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 1.93
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.9
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.9
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 1.9
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 1.9
Gene expression patterns define the hepatocyte-like cells derived by different strategies 1.87
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 1.87
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.82
Capturing the Interactome of Newly Transcribed RNA 1.82
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 1.74
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.73
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.69
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 1.69
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 1.67
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 1.67
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.67
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 1.65
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.65
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.65
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 1.63
Transcriptional responses of human insulinoma cells to acute cytokine exposure 1.61
Identifying the molecular mode of action of itraconazole in colorectal cancer 1.54
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.51
mRNA-Seq profiling of human developing kidney 1.5
Generating Patterned Kidney Organoids for Studying Development and Diseases 1.49
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 1.43
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 1.39
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 1.31
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.3
RNA sequencing of GlyH-101-treated MCF-7 cell line 1.29
Postnatal lipids drive hepatocyte maturation 1.27
Hepatocyte maturation 1.27
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.26
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.24
Repurposing of promoters and enhancers during mammalian evolution 1.17
Evaluating pre-clinical models for studying NASH driven HCC. 1.17
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 1.13
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.12
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.11
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.08
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.07
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.07
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 1.03
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.02
Cellular response to hepatitis E virus (HEV) infection 1.01
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 0.99
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 0.99
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.97
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.97
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 0.95
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 0.95
RNA-seq analysis of the human fetal kidney. 0.94
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 0.88
Global Mapping of Human RNA-RNA Interactions 0.88
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 0.83
The gene expression profiles of gallbladder cancer 0.8
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 0.8
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.78
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.78
circRNA-sequencing 0.77
Alagille_Nodder 0.76
RNA Seq of Alagille liver biopsies 0.76
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.76
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.75
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 0.74
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.74
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 0.7
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 0.7
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.7
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 0.69
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.69
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.68
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 0.68
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 0.68
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.67
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.66
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 0.65
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.65
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.64
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 0.63
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 0.62
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.62
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 0.61
DRB/GRO-Seq -/+ UV 0.61
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.61
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.61
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.61
Gene expression of collecting duct carcinoma of the kidney 0.6
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 0.59
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.59
Zone dependent distinctive gene expression profile of the normal human liver tissue 0.58
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 0.56
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 0.56
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.53
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.53
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.52
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.52
TT-Seq captures the human transient transcriptome 0.51
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.5
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.5
RNAseq analysis of ruxolitinib treated breast cancers 0.5
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 0.5
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.47
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.47
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 0.47
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 0.47
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 0.46
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 0.45
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 0.44
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.43
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.43
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.41
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.41
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.4
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.4
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.4
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 0.4
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.39
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 0.39
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 0.39
Identification of expressed and conserved human non-coding RNAs 0.39
Reassessment of Exosome Composition 0.38
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.38
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 0.35
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.35
Gene expression analysis upon mtDNA depletion 0.35
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 0.34
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.34
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 0.34
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.34
Epigenomic landscape during organ formation in human early embryos 0.33
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.33
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.33
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.32
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.32
Characterization of the Merkel cell carcinoma miRNome 0.31
UV_24h_GRO-Seq 0.31
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.31
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.31
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.31
The role of the Calcium-Sensing receptor in colorectal cancer 0.3
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 0.3
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.3
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.29
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.28
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.28
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.28
Targeted enhancer activation by a subunit of the integrator complex 0.27
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.27
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.27
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.27
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.27
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.26
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 0.26
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.26
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.26
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 0.26
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.26
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.26
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.25
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.25
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.25
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.25
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 0.25
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 0.25
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.25
Transcriptome of U251 cells overexpression complement component 7 0.25
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 0.24
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 0.24
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.24
Gene profiling of human adult and pediatric liver cancer cells 0.24
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 0.22
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 0.22
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 0.22
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 0.22
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.22
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.21
Derivation and differentiation of haploid human embryonic stem cells 0.21
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 0.2
Transcriptomic profile of human embryonic renal corpuscles 0.2
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.2
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.2
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 0.2
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 0.19
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 0.19
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.19
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 0.19
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.19
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.19
HEK293 Heat-shock experiment 0.18
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 0.18
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 0.18
circRNA-sequencing 0.18
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 0.17
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 0.17
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 0.17
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 0.17
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 0.17
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.16
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 0.16
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.16
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 0.16
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 0.16
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.16
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.16
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 0.16
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 0.16
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.16
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 0.15
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 0.15
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 0.15
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.15
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 0.15
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 0.15
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 0.15
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.14
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.14
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 0.14
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.14
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.14
Multiple sclerosis and EAE 0.14
Human optic chiasm from healthy controls and multiple sclerosis patients 0.14
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.14
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 0.14
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 0.14
Differential gene expression profiles in imatinib-resistant cell lines 0.14
RNA-Seq with and without RNase treatment in PCa cell lines 0.13
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.13
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 0.13
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.13
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.13
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 0.13
The pause-initiation limit restricts transcription activation in human cells 0.13
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 0.13
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 0.12
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.12
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 0.12
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 0.12
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 0.12
hnRNP C is a key regulator of protein synthesis in mitosis 0.12
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 0.12
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 0.12
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 0.12
RNA-sequencing of human liver tissue 0.12
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 0.12
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.12
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.12
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 0.12
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.11
Finding missing proteins from epigenetically manipulated human cells 0.11
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 0.11
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.11
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.11
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.11
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 0.11
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 0.11
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.11
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.11
Hepatosplenic T cell lymphoma 0.1
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.1
Intron retention induced by microsatellite expansions as a disease biomarker. 0.1
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.1
Deep RNA sequencing of the human placental transcriptome 0.1
Gene expression analysis of human adenomas. 0.1
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 0.1
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.1
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.1
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 0.1
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.1
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.1
A role for ZNF598 in post-transcriptional gene regulation 0.1
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.09
SRSF1 role in cellular gene expression and splicing 0.09
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 0.09
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.09
RNA m5C Methylation in breast cancer using MeRIP-Seq 0.09
Microglia innatly develop within cerebral organoids 0.09
Differentially expressed genes post knock down of lincDUSP26 0.09
RNA-seq of SCLC PDX models treated with EP 0.09
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.09
Iron response of HepG2 cells 0.09
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.09
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.09
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 0.08
Transcriptome analyses of human pancreatic islets and pseudoislets 0.08
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 0.08
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.08
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 0.08
Transcriptome of EBV-infected gastric cancer cell lines 0.08
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 0.08
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.08
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.08
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.07
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.07
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.07
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.07
LncRNA-GAS5 negative regulation of YAP-target genes expression 0.07
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 0.07
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 0.07
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.07
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 0.07
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.07
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 0.06
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 0.06
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.06
Transcriptomic analysis of the HOTAIR-regulated genes 0.06
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.06
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.06
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.06
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.06
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.06
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.06
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.06
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.06
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.06
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.06
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.05
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.05
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.05
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.05
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.05
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.05
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 0.05
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 0.05
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.05
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.04
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 0.04
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.04
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.04
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.04
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.04
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.04
Enhancer activation during EGF response 0.03
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.03
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.03
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.03
Differetially expressed genes after hTR overexpression in U2OS cells 0.03
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 0.03
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 0.03
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.03
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.03
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.03
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.03
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.03
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.03
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.03
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.03
ML29755 RNA-seq data 0.03
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.03
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.02
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.02
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 0.02
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.02
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.02
Studying the selectivity of a small molecule Synucleozid on transcriptome 0.02
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.02
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.02
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.02
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.02
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.02
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.02
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.02
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.02
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 0.02
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.02
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.02
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.02
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.02
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.02
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.02
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.02
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.01
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 0.01
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.01
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 0.01
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.01
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.01
Tyrosine Kinase Inhibitor Cardiotoxicity 0.01
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 0.01
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.01
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.01
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.01
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.01
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.01
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.0
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.0
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.0
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.0
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.0
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 0.0
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation